Furthermore, efforts are needed to further clarify more in-depth and specific molecular mechanisms of IGF2BP1 in various tumors, including its binding mode with target mRNAs, its regulation of downstream signaling pathways, and its dynamic changes during tumor progression. This evidence concerns the gene IGF2BP1 and neoplasm.